Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Karen Hauda is the Senior Director for Regulatory Policy in the Clinical Development, Medical and Regulatory Affairs Division at Novo Nordisk Inc. In this role, she supervises regulatory advocacy and policy, and develops strategies to positively influence the regulatory environment in the United States and globally.
Karen previously held roles at Abbott and AbbVie as Senior Director of Biologics Strategic Development, where she supervised biotherapeutic outreach strategies across all functions globally, and as a Senior Director within the Global Government Affairs and Policy division from 2007 to 2013. Prior to joining AbbVie, Karen served with the U.S. government from 1996 - 2007as a Patent and Trade Attorney.
Karen has additionally worked as an investigator for cancer gene therapy clinical trials at Johns Hopkins University and her research experience also has encompassed the study of the immune responses to parasitic diseases, including malaria, trichinella and schistosomiasis. Karen has several research publications in prominent peer-reviewed scientific journals. She has taught at universities and community colleges in the areas of intellectual property, trade, public health and emergency medical services and currently teaches in the Department of Global Health at George Washington University, in Washington, D.C.
Karen received a B.S. in Biochemistry and Molecular Biology and a M.S. in Veterinary Science with an emphasis in Immunology from the University of Wisconsin-Madison, and received her J.D. from the Columbus School of Law at the Catholic University of America. Karen is a member of the Virginia State Bar and the Patent Bar.